Postprandial hyperglycemia in type 2 diabetes mellitus patients can be controlled by inhibiting metabolic carbohydrate digesting enzymes such as alpha-amylase, alpha-glucosidase, and dipeptide peptidase IV19. The gene discussed is GAA; the disease is type 2 diabetes mellitus.